文献速递糖尿病

HbA1c快速下降与糖尿病视网膜病变早期恶化:2型糖尿病患者的真实世界人群研究

Rapid Reduction of HbA1c and Early Worsening of Diabetic Retinopathy: A Real-world Population-Based Study in Subjects With Type 2 Diabetes.
PubMed 文献 · Diabetes Care · 2023-01-01

该回顾性巢式病例对照研究基于SIDIAP数据库,纳入1150例发生糖尿病视网膜病变早期恶化(EWDR)的2型糖尿病伴轻中度非增殖性视网膜病变(NPDR)患者及1150例匹配对照,分析既往12个月HbA1c下降幅度与EWDR的关联。结果显示病例组与对照组HbA1c下降幅度无显著差异(0.13±1.21 vs 0.21±1.18;P=0.12),未调整与调整分析均未发现HbA1c快速下降与DR恶化显著相关。结论提示HbA1c快速下降与轻中度NPDR进展无关。

要点

  • 病例组与对照组HbA1c下降幅度无显著差异(0.13±1.21 vs 0.21±1.18;P=0.12)。
  • 未调整及调整主要混杂因素后,HbA1c下降与DR恶化均无显著关联。
  • 按基线HbA1c分层后,基线HbA1c较高者未呈现更高的EWDR风险。

核心结论

  • 研究结果提示HbA1c快速下降与轻中度NPDR的进展无关。

研究设计与样本

  • 回顾性巢式病例对照研究,使用SIDIAP数据库。
  • 纳入2型糖尿病伴既往轻或中度NPDR者,选取1150例EWDR个体与1150例匹配对照(DR无EWDR)。
  • 主要分析变量为既往12个月HbA1c下降幅度,并将HbA1c下降分类为快速(12个月内下降>1.5%)或极快速(6个月内下降>2%)。

主要发现

  • 病例组与对照组HbA1c下降幅度无显著差异(0.13±1.21 vs 0.21±1.18;P=0.12)。
  • HbA1c下降与DR恶化在未调整分析中无显著关联,在调整糖尿病病程、基线HbA1c、高血压存在及降糖药物的统计模型中亦无显著关联。
  • 按基线HbA1c分层后,基线HbA1c较高的患者未呈现更高的EWDR风险。

关键数值与推荐

  • HbA1c快速下降定义为12个月内下降>1.5%。
  • HbA1c极快速下降定义为6个月内下降>2%。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Early worsening of diabetic retinopathy (EWDR) due to the rapid decrease of blood glucose levels is a concern in diabetes treatment. The aim of the current study is to evaluate whether this is an important issue in subjects with type 2 diabetes with mild or moderate nonproliferative DR (NPDR), who represent the vast majority of subjects with DR attended in primary care. RESEARCH DESIGN AND METHODS: This is a retrospective nested case-control study of subjects with type 2 diabetes and previous mild or moderate NPDR. Using the SIDIAP ("Sistema d'informació pel Desenvolupament de la Recerca a Atenció Primària") database, we selected 1,150 individuals with EWDR and 1,150 matched control subjects (DR without EWDR). The main variable analyzed was the magnitude of the reduction of HbA1c in the previous 12 months. The reduction of HbA1c was categorized as rapid (>1.5% reduction in <12 months) or very rapid (>2% in <6 months). RESULTS: We did not find any significant difference in HbA1c reduction between case and control subjects (0.13 ± 1.21 vs. 0.21 ± 1.18; P = 0.12). HbA1c reduction did not show significant association with worsening of DR, neither in the unadjusted analyses nor in adjusted statistical models that included the main confounding variables: duration of diabetes, baseline HbA1c, presence of hypertension, and antidiabetic drugs. In addition, when stratification by baseline HbA1c was performed, we did not find that those patients with higher levels of HbA1c presented a higher risk to EWDR. CONCLUSIONS: Our results suggest that the rapid reduction of HbA1c is not associated with progression of mild or moderate NPDR.

来源:Diabetes Care,查看原文。版权归原作者所有。

引用

  1. Simó R, Franch-Nadal J, Vlacho B, et al. Rapid Reduction of HbA1c and Early Worsening of Diabetic Retinopathy: A Real-world Population-Based Study in Subjects With Type 2 Diabetes. Diabetes Care. 2023. PMID: 37428631. doi:10.2337/dc22-2521

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。